Finally, we would like to thank the Canadian Institute of Health Research Canada for funding this research program (grant #440390). Footnotes Appendix ASupplementary data to this article can be found online at https://doi.org/10.1016/j.nano.2022.102584. Appendix A.?Supplementary data Supplementary material Click here to view.(1.0M, pdf)Image 1. Graphical abstract The papaya mosaic disease nanoparticle (PapMV nano) vaccine platform is an inducer of the innate immune system and Talabostat it is therefore an excellent tool for the development of vaccines. To produce the COVID-19 vaccine candidate, the surface of PapMV nano was couple to the SARS-CoV-2 receptor-binding website (RBD) to generate the RBD-PapMV candidate vaccine. Immunization with the RBD-PapMV vaccine resulted in high levels of antibodies directed to RBD that neutralized the infection of the ancestral SARS-CoV-2, as well as the delta, and omicron variants in cell tradition. The immune response elicited by RBD-PapMV also safeguarded vulnerable transgenic mice from SARS-CoV-2 illness and purified by ion matrix affinity chromatography (IMAC) as previously reported37. RBD The RBD protein (aa 331C591, accession no. “type”:”entrez-nucleotide”,”attrs”:”text”:”NC_045512.2″,”term_id”:”1798174254″,”term_text”:”NC_045512.2″NC_045512.2), production and purification of the protein were previously reported52. Coupling reaction with Talabostat Sortase A transpeptidase Coupling of recombinant RBD to the surface of PapMV nano using Sortase A was previously explained37., 39.. The optimal percentage of RBD:Sortase:PapMV nano (in M) for this reaction was 30:50:50. The uncoupled RBD and free SrtA were eliminated by dialysis. The final product was stored at 4 C. Analytical analysis of the RBD-PapMV vaccine SDS-PAGE and assessment of coupling effectiveness The intensity of the protein bands as observed by SDS-PAGE, were quantified using the software ImageJ (version 1.49) (free software; https://imagej.nih.gov/ij/index.html). The coupled band (RBD-PapMV CP) has a molecular excess weight equivalent to the sum of the RBD and PapMV CP. The coupling effectiveness is defined as a percentage determined using the area under the curve (AUC) of coupled and non-coupled PapMV CP bands: using a microneutralization assay (MNA) previously explained54. The SARS-CoV-2 ancestral, Delta, and Omicron variants, as well as the permissive cell collection Vero.E6 were kindly provided by the INSPQ. In brief, sera from immunized mice were warmth inactivated Rabbit polyclonal to PAX2 at 56 C for 1 h. Then, mice sera and a monoclonal antibody (MAb) against the Spike protein (Complete Antibody, UK, 3 g/ml), used like a positive control, were diluted 1/10 followed by 1/3 serial dilutions. Each dilution was incubated with 20 TCID50 of SARS-CoV-2 for 1 h at space temperature and used to infect Vero.E6 cell monolayers. Then, the infectious combination was removed, and cells were incubated Talabostat for 72 h with press comprising sera or MAb at the same dilutions54. Cells not exposed to the disease were the negative settings (no disease), while cells treated with disease alone were the positive control of illness (disease only). Finally, the cell monolayers were fixed with formaldehyde 4 %. The amount of disease was assessed by immunostaining of the viral nucleoprotein (N) with an anti-N polyclonal antibody (Rockland) from rabbit, followed by an anti-rabbit IgG secondary antibody conjugated to peroxidase (Jackson Immunoresearch, USA). The optical denseness measured at 450 nm from samples and settings was used to calculate the percentage of illness using the following method: 100 C ((ODx C Average of no disease wells) / (Average of disease only wells C Average of no disease wells) * 100), where X corresponds to the absorbance for each sample. Non-linear regression curve match analysis was performed to determine the ID50 values. Assessment of viral titer in lungs and nose turbinates SARS-CoV-2 titers in the lung and nose turbinate of infected K18-hACE2 transgenic mice were assessed by end-point titration as previously explained55. Lungs and nose turbinate were harvested at 2 and 5 d.p.i. and homogenized. The cytopathic effect for each sample was recorded and the TCID50 were computed using the ReedCMuench method56. Titers were indicated as log10 of TCID50/g55. Assessment of pro-inflammatory cytokines in the lung The levels of pro-inflammatory cytokines interleukin (IL)-6, tumor necrosis element (TNF)-alpha and the chemokine KC/GRO (CXCL1) in the lungs of SARS-CoV-2 infected K18-hACE2 mice was measured using a V-Plex custom cytokine panel (Meso Scale Finding – MSD, USA), according to the manufacturer’s instructions. The concentration of cytokines in lung homogenate was determined by interpolation of the calibrator’s curves as explained by the manufacturer. Lung histopathology For assessing the pulmonary cells inflammatory response histologically after SARS-CoV-2 (ancestral strain) challenge, lungs of K18-hACE2 Talabostat transgenic mice were extracted at 5 d.p.i. The remaining lung was fixed with 10 %10 % buffered.